{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:43:19Z","timestamp":1793295799302,"version":"4.5.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>The aim of this study was to analyze the clinical manifestations of adverse reactions after the use of SonoVue contrast agent from a large retrospective database, and to evaluate the nursing care strategies and the efficacy of standardized procedure for adverse reactions of SonoVue (SPARS).<\/jats:p>\n            <jats:p>From January 1, 2012 to December 30, 2018, 34,478 cases of contrast-enhanced ultrasonography were performed in our center. The clinical manifestations of adverse reactions after the use of SonoVue contrast agent were identified and analyzed. The nursing care strategies were evaluated and the outcomes of patients with moderate and severe adverse reactions before and after the application of SPARS were compared.<\/jats:p>\n            <jats:p>Of the 34,478 cases, 40 cases (0.12%) of adverse reactions after the use of SonoVue were identified. Adverse reactions included anaphylatic shock, skin allergies, nausea or vomiting, dizziness or headache, numbness, chest distress, back pain, and local reactions of the injection site. Most of the adverse reactions were mild and self-limited. Only 3 cases of anaphylatic shock and 2 cases of severe rash underwent further treatments. The 3 patients who were managed by SPARS recovered quicker and spent less comparing with the other 2 patients who were not.<\/jats:p>\n            <jats:p>SonoVue was a safe contrast agent, with few and mostly mild adverse reactions. SPARS may be an efficient way in tackling moderate to severe adverse reactions, although of which the incidence was rare.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000017745","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T19:38:47Z","timestamp":1572896327000},"page":"e17745","source":"Crossref","is-referenced-by-count":59,"title":["Adverse reactions after the use of SonoVue contrast agent"],"prefix":"10.1097","volume":"98","author":[{"given":"Chenlu","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Interventional Ultrasound"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinger","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Interventional Ultrasound"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pintong","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Interventional Ultrasound"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingfen","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Nursing, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,11]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0003-3928(02)00109-9","article-title":"Contrast media in ultrasonography: from synthesis to clinical use. The SonoVue example","volume":"51","author":"Schneider","year":"2002","journal-title":"Ann Cardiol Angiol"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2214\/AJR.09.2553","article-title":"Contrast-enhanced ultrasound: what is the evidence and what are the obstacles?","volume":"193","author":"Wilson","year":"2009","journal-title":"Am J Roentgenol"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00330-004-2601-0","article-title":"Safety of ultrasound contrast agents","volume":"15","author":"Jakobsen","year":"2005","journal-title":"Eur Radiol"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2459\/JCM.0b013e328319bfba","article-title":"Adverse reactions after the use of sulphur hexafluoride (SonoVue) echo contrast agent","volume":"10","author":"Geleijnse","year":"2009","journal-title":"J Cardiovasc MED"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.ultrasmedbio.2006.05.031","article-title":"The safety of SonoVue in abdominal applications: retrospective analysis of 23,188 investigations","volume":"32","author":"Piscaglia","year":"2006","journal-title":"Ultrasound Med Biol"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.euje.2005.02.003","article-title":"Adverse reactions to ultrasound contrast agents: is the risk worth the benefit?","volume":"6","author":"Dijkmans","year":"2005","journal-title":"Eur J Echocardiogr"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.anai.2011.12.011","article-title":"Anaphylactic shock due to SonoVue","volume":"108","author":"Levano","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.exger.2018.03.019","article-title":"Limb muscle quality and quantity in elderly adults with dynapenia but not sarcopenia: an ultrasound imaging study","volume":"108","author":"Chang","year":"2018","journal-title":"Exp Gerontol"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.apmr.2017.01.022","article-title":"Static and dynamic shoulder imaging to predict initial effectiveness and recurrence after ultrasound-guided subacromial corticosteroid injections","volume":"98","author":"Chang","year":"2017","journal-title":"Arch Phys Med Rehabil"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3389\/fneur.2018.00902","article-title":"Basis of shoulder nerve entrapment syndrome: an ultrasonographic study exploring factors influencing cross-sectional area of the suprascapular nerve","volume":"9","author":"Wu","year":"2018","journal-title":"Front Neurol"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF03085955","article-title":"Clinical usefulness of SonoVue contrast echocardiography: the Thorax centre experience","volume":"15","author":"Galema","year":"2007","journal-title":"Neth Heart J"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejogrb.2014.07.030","article-title":"Contribution of contrast-enhanced ultrasound with SonoVue to describe the microvascularization of uterine fibroid tumors before and after uterine artery embolization","volume":"181","author":"Henri","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1148\/radiology.203.3.9169676","article-title":"Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration","volume":"203","author":"Lasser","year":"1997","journal-title":"Radiology"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1517\/14740338.4.3.399","article-title":"Adverse effects associated with SonoVue use","volume":"4","author":"Torzilli","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-0044-101254","article-title":"The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (short version)","volume":"39","author":"Sidhu","year":"2018","journal-title":"Ultraschall Med"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ultrasmedbio.2012.09.002","article-title":"Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver \u2013 update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS","volume":"39","author":"Claudon","year":"2013","journal-title":"Ultrasound Med Biol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017745","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:36:23Z","timestamp":1694824583000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017745"}},"subtitle":["Characteristics and nursing care experience"],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":16,"journal-issue":{"issue":"44","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000017745","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}